Report Overview:
Medical blood lancets are small, pricking needles used to obtain blood samples for testing. They are primarily utilized by individuals suffering from cardiovascular and endocrine disorders, such as diabetes, to monitor blood glucose levels. These devices are designed for single-use applications to ensure hygiene and prevent cross-contamination.
Market Value:
The global medical blood lancet market was valued at USD 1,857 million in 2024 and is anticipated to reach USD 2,905.60 million by 2032, growing at a CAGR of 5.10% during the forecast period. CAGR of 5.10% (2025 – 2032)
By Types:
• Safety Lancets
• Ordinary Lancets
By Applications:
Hospitals & Clinics
Home Use
Key players include:
• Cardinal Health
• ARKRAY
• ICU Medical
• Owen Mumford
• HemoCue
• Greiner Bio One
• Including or Excluding key companies relevant to your analysis.
